COLUMBIA UNIVERSITY HEALTH SCIENCES
Engineered probiotic bacteria for colorectal cancer immunoprevention and interception
Engineered probiotic bacteria for colorectal cancer immunoprevention and interception is a funding opportunity from COLUMBIA UNIVERSITY HEALTH SCIENCES, up to 727904, closing May 31, 2027.
May 31, 2027
(304d left)Overview
PROJECT SUMMARY Synthetic biology is driving a new era of medicine through the genetic programming of living cells. One particular focus has been the engineering of bacteria as therapeutic delivery systems to selectively release therapeutic payloads in vivo. Since colorectal cancer (CRC) initiation and progression are…